Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
A dedicated Phase 2b trial in MASLD and MASH patients is currently ongoing, with Phase 3 studies planned
Tirzepatide works by: Slowing gastric emptying , which prolongs the feeling of fullness after meals Reducing appetite through effects on brain centres that regulate hunger Improving insulin secretion in response to elevated blood glucose Decreasing glucagon secretion , which helps lower blood sugar levels Clinical trials have demonstrated that tirzepatide can lead to substantial weight losswith dose-dependent reductions of approximately 1520% of body weight over 72 weekswhen combined with lifestyle modifications
North America dominated the market share in 2025 with 75.46% share
Budy includes nutrition targets, meal recommendations, meal actions, and AI nutrition support where available, so training and food decisions can share context
US$ 21.22
US$ 27.33
US$ 22.62
US$ 22.29
